Treatment With Peginterferon Alfa-2a (40 KD) of Chronic Hepatitis B Patients, Who Have Failed Anti-viral Treatment
Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
This study is to investigate the HBV DNA suppression (and HBeAg seroconversion among HBeAg
positive patients) pegylated interferon treatment at 24 weeks after end of treatment among
patients who have failed anti-viral treatment in the past.